Gsk Share Discussion Threads

[anhar] 06/3/2015 09:34

...the share price is at a discount of up to 20% against its peers...so the 83p is an added consideration not necessarily in the price.Personally here for the Dividend yield and general perceived safety in the current global situation...

In my income strategy, I measure the discount of a share to the market rather than to its sector peers. On this basis GSK, which I've held it for several years, on an 80p normal div is yielding 5.1% at 1,567p. With the market on a trailing yield of 2.5%, this means that GSK is on a discount of 51%.

Another way of looking at it, and the one I use, is that to match the market yield GSK would have to be 3,197p right now which would be my exit price.

The exit price fluctuates constantly with the market yield and the share's divis.

The 83p special, if is accompanied by a share consolidation which these payments usually are, means that we don't gain anything. We end up with fewer shares and some cash, effectively a compulsory sale of part of the holding. It's not the same as a normal divi so I don't take that into account in my method.

[madengland] 05/3/2015 20:34

Lol supermarky. It was a great year, unless you were a spud of course

[supermarky] 05/3/2015 20:18

The magic potato number of 1570 pr there abouts still holds. share price has spring in it but can it head north of the magic number after such a good run in the last 3 months. I'm waiting for evidence of more immediate upside before joining the ride again

[madengland] 05/3/2015 20:01

Ps GSK is my biggest holding of a single share ever..... Aside from a similar holding in McDonalds that did me well from 15 to 100, luck and a wee bit of understanding more than Joe analyst. I do feel GSK to be a very nice play in these uncertain times.

[madengland] 05/3/2015 19:57

Many thanks. Yes I am not particularly big on TA hence a quick glimpse on my rather clunky websites, probably why my lines ain't yet crossed as I know one line is simple and the other not. To qualify my lack of TA, I have been sceptical of its benefit as most of my portfolio is small cap or smaller. Gradually buying up some large cap divi stocks, so I am more intrigued as I do think it can add a perspective, so thanks for the post you've shared. 1750 would be nice hey

[philo124] 05/3/2015 19:55

I liked the Novartis deal.

[tradermichael] 05/3/2015 19:31

Thanks guys. Close alignment to the FTSE trend, and an impressive breakout it seems.

[s2lowner] 05/3/2015 17:26

Madengland
I have done a screencast (above post) with 50/200 exp ma.

The way I read it they crossed a few days ago, the last time they crossed the shares went on a run to over 17.5

They seem to need the ftse 100 to do well in order to have a good run

I am a holder

[woodhawk] 05/3/2015 16:53

Yes, Madengland, that goat is history!

[madengland] 05/3/2015 16:13

I can't seem to cut and paste charts I am afraid. The Bloomberg ones I use suggest the 50 day ma is about the bisect the 200 day ma. Plus wood hawk is about to sacrifice a goat. All bodes well to 1700. Well here's hoping and guessing

[tradermichael] 05/3/2015 15:18

Anybody got Moving Average Charts, please?

[cyberian] 04/3/2015 16:03

According to quite a few posters here there is more to come on the upside with potential IPO next year being reviewed by three major Intl. Banks appointed by the company. Plus further cost savings both headcount and new processing techniques, and the share price is at a discount of up to 20% against its peers...so the 83p is an added consideration not necessarily in the price.Personally here for the Dividend yield and general perceived safety in the current global situation.

[jadeticl3] 04/3/2015 14:20

If we get B shares worth 83p per share is the share price set to fall by that amount once we have been paid out (or once new buyers no longer qualify)? Does this presuppose that the share price now has this 83p built into the price? Or is it set to rise to account for this once we have the details in early May?

[tradermichael] 04/3/2015 12:50

Don't worry, latest Analyst says 1670p ...... ;0)

[philo124] 04/3/2015 11:53

I thought we had left 1550p behind us.

[philanderer] 04/3/2015 11:46

GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating reissued by stock analysts at Goldman Sachs in a report issued on Tuesday. They currently have a 1670p price target on the stock.

[tradermichael] 04/3/2015 08:04

MUMBAI: Sun Pharmaceutical Industries LtdBSE 9.60 %, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

The business consists of analgesics made from raw materials
found in opium poppy plants, and includes two manufacturing sites in the states
of Tasmania and Victoria.

Read more at:

[philo124] 03/3/2015 11:56

Next update on that 6th May.

[cyberian] 03/3/2015 11:16

Does anyone know when the qualifying date is for when the new "B" shares are to be insued.....will it be like when the shares go XD a few weeks after quarterly results?

[supermarky] 03/3/2015 09:30

Going to buy some potatoes with my lovely profit lol

[supermarky] 03/3/2015 09:29

Out at 1570.

[toffeeman] 03/3/2015 09:26

No but they work as well as herding cats

[mr woodentop] 03/3/2015 09:06

Do Broker notes work as well as slaughtering goats?